Compare Stocks: IOVA vs. IDYA vs. RLAY vs. ELVN
Compare normalized stock price performance over 6 months, 1 year or 2 years. Each line starts at 0%, so different stock prices can be compared on the same scale.
IOVAIDYARLAYELVN
Market Snapshot
Current market context for the selected companies.
IOVA
$8.71
Market Cap
$3.94B
Sector
Healthcare
Industry
Biotechnology
Data through
2026-09-03
IDYA
$39.93
Market Cap
$3.86B
Sector
Healthcare
Industry
Biotechnology
Data through
2026-09-03
RLAY
$18.99
Market Cap
$4.17B
Sector
Healthcare
Industry
Biotechnology
Data through
2026-09-03
ELVN
$59.59
Market Cap
$4.37B
Sector
Healthcare
Industry
Biotechnology
Data through
2026-09-03
Performance
Absolute returns and relative performance versus SPY.
| Metric | IOVA | IDYA | RLAY | ELVN |
|---|---|---|---|---|
| 1 Month | +100.8% | +10.8% | -3.6% | -0.2% |
| 1 Month vs SPY | +100.4% | +10.4% | -3.9% | -0.6% |
| 3 Months | +99.0% | +36.7% | +30.6% | +67.9% |
| 3 Months vs SPY | +96.9% | +34.6% | +28.5% | +65.8% |
| 6 Months | +90.3% | +20.9% | +97.0% | +103.4% |
| 6 Months vs SPY | +76.9% | +7.5% | +83.6% | +90.0% |
| 1 Year | +294.3% | +55.0% | +362.0% | +184.4% |
| 1 Year vs SPY | +274.3% | +35.0% | +342.0% | +164.4% |
| 2 Years | -23.4% | +1.9% | +180.9% | +168.2% |
| 2 Years vs SPY | -61.8% | -36.5% | +142.5% | +129.8% |
Growth & Profitability
Operating growth, margins and capital efficiency.
Valuation
Common valuation multiples shown side by side.
Cash Flow & Balance Sheet
Cash generation and leverage context.
Earnings Outlook
Upcoming earnings expectations when available.